Clinical
Pharmacists cite concern over ‘blowback’
Fear of repercussions is a barrier to reporting medication errors, but safe reporting cultures can help, says professional officer A small qualitative study on medication error reporting has found that …
Mixed news on Vyvanse shortage
There has been good, and bad, news about the ongoing shortage of the ADHD treatment The Therapeutic Goods Administration (TGA) has an update informing of mixed news about ongoing shortages …
Consumer group backs compounding ban
The CHF has said it ‘understands’ why the TGA is proposing a ban on pharmacists compounding Ozempic, but more must be done to boost supply Consumers Health Forum of Australia …
Update on morphine
Approval granted for the supply of overseas-registered morphine oral liquid products and new supply arrangements following Ordine discontinuation The Therapeutic Goods Administration (TGA) has granted approval for the supply of …
No consensus on vaping products
With pharmacies to become the only legal source of nicotine vaping products from 1 March, a study has found that pharmacists and authorised prescribers may differ on their use for …
Telehealth gets tick of approval
Pharmacists participating in ward rounds via telehealth ramped up activities for Covid-19 patients compared to face-to-face attendance, study finds Hospital pharmacists can successfully deliver services and participate in medical ward …
Gaps and inequities
One specialist cancer pharmacist has spoken out about the “postcode lottery” of limitations to PBS funding depending on a patient’s treatment location The Society of Hospital Pharmacists of Australia’s head …
‘Really robust’ collaboration trial hoped to set standard
Researchers aim to help set collaborating prescribing practices as Australia’s expected standard of care, with a new project on reducing hospital medication errors Pharmacists are partnering with patients and doctors …
Substitution arrangement for fluoxetine
Temporary approval granted for replacement oral fluoxetine product as shortage continues Due to the shortage of fluoxetine (brand name: Zactin Tablet), the Federal Department of Health has announced it has …
Promising findings on pharmacist UTI management
Evidence suggests “promise” of safe and effective management of UTIs by community pharmacists, but more research is needed, and a viable economic model is crucial While the available evidence suggests …
